Claire De Canecaude

Toulouse, 31000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

When generative AI goes off the rails and leads to adverse drug reactions.

When generative AI goes off the rails and leads to adverse drug reactions.

Journal: Therapie

Published: May 26, 2026

Applying machine learning to pharmacovigilance data: A proof-of-concept study.

Applying machine learning to pharmacovigilance data: A proof-of-concept study.

Journal: British journal of clinical pharmacology

Published: January 09, 2026

Beyond vancomycin: Pharmacovigilance detects new drugs involved in linear IgA bullous dermatosis.

Beyond vancomycin: Pharmacovigilance detects new drugs involved in linear IgA bullous dermatosis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 07, 2025

Can large language models detect drug-drug interactions leading to adverse drug reactions?

Can large language models detect drug-drug interactions leading to adverse drug reactions?

Journal: Therapeutic advances in drug safety

Published: October 24, 2024

Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.

Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.

Journal: Expert opinion on drug safety

Published: August 16, 2023

Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice.

Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice.

Journal: European journal of clinical pharmacology

Published: June 13, 2023

Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions.

Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions.

Journal: Therapie

Published: March 27, 2023

Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias.

Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 17, 2023

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19).

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19).

Journal: Therapie

Published: February 03, 2023

Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019.

Increased reporting of venous and arterial thromboembolic events reported with tixagevimab-cilgavimab for coronavirus disease 2019.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: July 18, 2022

Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database.

Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database.

Journal: British journal of clinical pharmacology

Published: July 12, 2022

Severe hepatitis after sevoflurane anesthesia in an 8-month old child with a Down syndrome: Case report and review of the literature.

Severe hepatitis after sevoflurane anesthesia in an 8-month old child with a Down syndrome: Case report and review of the literature.

Journal: Therapie

Published: July 11, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026